Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q1 2021 Results Earnings Conference Call May 12, 2021 4:30 PM ET Company Participants Tim McCarthy - LifeSci Advisors Sergio Traversa - Chief Executive Officer Chuck Ence - Chief Accounting and Compliance Officer Conference Call Participants Andrew Tsai - Jefferies Joon Lee - Truist Yatin Suneja - Guggenheim Partners Jay Olson - Oppenheimer Operator Good afternoon, ladies and gentlemen. And thank you for standing by. Welcome to the Relmada Therapeutics Incorporated F ...